Cagri + Sema
Dual-pathway combination of Cagrilintide and Semaglutide for maximum appetite control and sustainable weight loss.
$185.00 / unit
1
Total:$185.00
GMP Compliant≥99% PurityGlobal Shipping
The uniqueness of CagriSema lies in its ability to exert a synergistic effect through two different pathways. Semaglutide (GLP-1 agonist) increases satiety by delaying gastric emptying and inhibiting the appetite center. Cagrilintide (amylin analogue) enhances satiety signals by activating areas in the brain responsible for regulating appetite.
Key Benefits
- Dual-pathway appetite and metabolic synergy
- Significantly reduces energy intake
- Helps counteract metabolic adaptation during weight loss
- Maintains higher energy expenditure during caloric deficit
- Once-weekly dosing for convenience
Reconstitution Instructions
- Reconstitute with Bacteriostatic Water
- Gently swirl until dissolved
Dosing Guidelines
- Cagri-Sema combination administered once weekly
- Start with lower doses and titrate up
Product Note
One of the most powerful combination therapies for obesity management with clinically proven outcomes.